Clinical Trials Browser

OTHER × Fatty Acids, Omega-3 × 90 days × Clear all

NCT02295059 2026-04-03

Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention

Phase NA Active not recruiting

Breast Neoplasms